短链脂肪酸减轻破骨细胞介导的关节炎性骨重塑
该研究在银屑病关节炎小鼠模型R26STAT3Cstopfl/fl CD4Cre中评估短链脂肪酸(SCFA)对骨重塑的影响,发现补充SCFA可挽救骨质疏松表型,体外实验显示SCFA即使在极低血清浓度下也抑制破骨细胞分化,机制涉及骨髓破骨细胞祖细胞SCFA受体表达升高及转录组改变。
要点
- SCFA补充可挽救R26STAT3Cstopfl/fl CD4Cre小鼠的骨质疏松表型。
- SCFA在极低血清浓度下即可抑制破骨细胞分化。
- 患病小鼠骨髓破骨细胞祖细胞的SCFA受体表达高于对照小鼠。
核心结论
- 肠道菌群来源的SCFA可调控远端病理(即骨质疏松),并鉴定出恢复风湿病骨密度的潜在治疗选择,进一步凸显肠-骨轴在这些疾病中的关键作用。
研究设计与样本
- 研究采用银屑病关节炎临床前小鼠模型R26STAT3Cstopfl/fl CD4Cre,给予SCFA补充饮水处理。
- 体外进行破骨细胞分化实验,在血清水平SCFA存在下评估其对破骨细胞成熟与功能的直接影响。
- 通过转录分析进一步刻画SCFA的分子机制。
主要发现
- R26STAT3Cstopfl/fl CD4Cre动物的骨质疏松主要归因于破骨细胞祖细胞(OCP)扩增驱动的强烈破骨细胞分化,并伴有成骨细胞发育受损。
- SCFA补充可挽救该银屑病关节炎模型的骨质疏松表型。
- 体外实验显示SCFA即使在极低血清浓度下也抑制破骨细胞分化。
- 对破骨细胞分化的抑制使SCFA能够阻止R26STAT3Cstopfl/fl CD4Cre小鼠骨质疏松的发展。
- 患病小鼠骨髓来源OCP的SCFA受体表达高于对照小鼠,SCFA处理小鼠骨髓祖细胞呈现转录组景观改变,提示SCFA在骨质疏松背景下对骨髓祖细胞有直接影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective for this study was to evaluate the effects of short chain fatty acids (SCFAs) on arthritic bone remodeling. METHODS: We treated a recently described preclinical murine model of psoriatic arthritis (PsA), R26STAT3Cstopfl/fl CD4Cre mice, with SCFA-supplemented water. We also performed in vitro osteoclast differentiation assays in the presence of serum-level SCFAs to evaluate the direct impact of these microbial metabolites on maturation and function of osteoclasts. We further characterized the molecular mechanism of SCFAs by transcriptional analysis. RESULTS: The osteoporosis condition in R26STAT3Cstopfl/fl CD4Cre animals is attributed primarily to robust osteoclast differentiation driven by an expansion of osteoclast progenitor cells (OCPs), accompanied by impaired osteoblast development. We show that SCFA supplementation can rescue the osteoporosis phenotype in this model of PsA. Our in vitro experiments revealed an inhibitory effect of the SCFAs on osteoclast differentiation, even at very low serum concentrations. This suppression of osteoclast differentiation enabled SCFAs to impede osteoporosis development in R26STAT3Cstopfl/fl CD4Cre mice. Further interrogation revealed that bone marrow-derived OCPs from diseased mice expressed a higher level of SCFA receptors than those of control mice and that the progenitor cells in the bone marrow of SCFA-treated mice presented a modified transcriptomic landscape, suggesting a direct impact of SCFAs on bone marrow progenitors in the context of osteoporosis. CONCLUSION: We demonstrated how gut microbiota-derived SCFAs can regulate distal pathology (ie, osteoporosis) and identified a potential therapeutic option for restoring bone density in rheumatic disease, further highlighting the critical role of the gut-bone axis in these disorders.
引用
- Yang KL, Mullins BJ, Lejeune A, et al. Mitigation of Osteoclast-Mediated Arthritic Bone Remodeling By Short Chain Fatty Acids. Arthritis Rheumatol. 2024. PMID: 37994265. doi:10.1002/art.42765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。